PortfoliosLab logo

Autolus Therapeutics plc (AUTL)

Equity · Currency in USD · Last updated Feb 4, 2023

Company Info

ISINUS05280R1005
CUSIP05280R100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.03
Year Range$1.74 - $4.68
EMA (50)$2.11
EMA (200)$2.77
Average Volume$744.51K
Market Capitalization$351.31M

AUTLShare Price Chart


Loading data...

AUTLPerformance

The chart shows the growth of $10,000 invested in Autolus Therapeutics plc in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $812 for a total return of roughly -91.88%. All prices are adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%OctoberNovemberDecember2023February
-37.35%
4.28%
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLCompare to other instruments

Search for stocks, ETFs, and funds to compare with AUTL

Autolus Therapeutics plc

AUTLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M8.56%8.17%
YTD6.84%7.73%
6M-37.54%-0.37%
1Y-49.75%-9.87%
5Y-41.99%9.22%
10Y-41.99%9.22%

AUTLMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202313.16%
202218.28%-35.15%33.18%-7.37%-28.03%

AUTLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Autolus Therapeutics plc Sharpe ratio is -0.57. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20OctoberNovemberDecember2023February
-0.57
-0.41
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLDividend History


Autolus Therapeutics plc doesn't pay dividends

AUTLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-95.77%
-13.76%
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLWorst Drawdowns

The table below shows the maximum drawdowns of the Autolus Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Autolus Therapeutics plc is 96.38%, recorded on Dec 13, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.38%Nov 12, 20181029Dec 13, 2022
-27.36%Sep 11, 201823Oct 11, 201820Nov 8, 201843
-24.83%Jun 27, 201812Jul 13, 201821Aug 13, 201833
-5.65%Aug 20, 20184Aug 23, 201810Sep 7, 201814
-0.82%Aug 14, 20181Aug 14, 20181Aug 15, 20182

AUTLVolatility Chart

Current Autolus Therapeutics plc volatility is 77.50%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%OctoberNovemberDecember2023February
77.50%
16.33%
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)